Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Deer Park, Illinois
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 422 filings
- On EDGAR
- CIK 1710340
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 35
News 8 of 156
Prospectuses and Registrations 8 of 22
- S-8 Registration statement for an employee plan Mar 6, 2026
- S-8 Registration statement for an employee plan Nov 19, 2025
- 424B5 Prospectus supplement for an offering Dec 12, 2024
- S-8 Registration statement for an employee plan Mar 26, 2024
- S-3 Shelf registration statement Apr 7, 2023
- S-8 Registration statement for an employee plan Mar 21, 2023
- 424B3 Prospectus supplement for an offering Apr 9, 2021
- 424B3 Prospectus supplement for an offering Apr 7, 2021
Proxies 8 of 10
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2021
- DEFA14A Extra proxy material Apr 22, 2020
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2020
Ownership 8 of 175
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- 4 Insider reported a trade Oct 6, 2026
- 144 Notice of a proposed sale of restricted stock Oct 6, 2026
- 4/A Insider reported a trade, amended Aug 31, 2026
- 4 Insider reported a trade Aug 28, 2026
- 144 Notice of a proposed sale of restricted stock Aug 28, 2026
- 4 Insider reported a trade Aug 24, 2026
- 144 Notice of a proposed sale of restricted stock Aug 24, 2026
Other 8 of 24
- UPLOAD Comment letter from SEC staff Jan 27, 2026
- CORRESP Reply to SEC staff Jan 14, 2026
- UPLOAD Comment letter from SEC staff Dec 19, 2025
- EFFECT Notice that a registration became effective May 2, 2023
- CORRESP Reply to SEC staff May 1, 2023
- UPLOAD Comment letter from SEC staff Apr 12, 2023
- NT 10-Q Notice that a quarterly report will be late Nov 16, 2021
- EFFECT Notice that a registration became effective Aug 25, 2020
Everything here comes from Eton Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.